Finance

Lists
Why is 300759 down 2.50%?
Dive Deeper
300759:SHE
Pharmaron Beijing Co Ltd
CNÂ¥39.00
-2.50%
(-1.00) 1D
Oct 15, 2:54:58 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300759...
Open
CNÂ¥39.18
High
CNÂ¥40.35
Low
CNÂ¥38.76
Mkt. cap
68.69B
Avg. vol.
46.53M
Volume
27.95M
Dividend
0.51%
Quarterly dividend
CNÂ¥0.05
Ex-dividend date
Jul 7, 2026
P/E ratio
41.02
52-wk high
CNÂ¥53.57
52-wk low
CNÂ¥21.01
EPS
CNÂ¥0.95
Shares outstanding
1.48B
No. of employees
27K
Open
CNÂ¥39.18
High
CNÂ¥40.35
Low
CNÂ¥38.76
Mkt. cap
68.69B
Avg. vol.
46.53M
Volume
27.95M
Dividend
0.51%
Quarterly dividend
CNÂ¥0.05
Ex-dividend date
Jul 7, 2026
P/E ratio
41.02
52-wk high
CNÂ¥53.57
52-wk low
CNÂ¥21.01
EPS
CNÂ¥0.95
Shares outstanding
1.48B
No. of employees
27K
News stories
From web sources and news partners
About Pharmaron Beijing Co Ltd
CEOBoliang Lou
Employees27.3K
FoundedJul 1, 2004
Headquarters-
SectorHealth care
Websitepharmaron.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
3.64B
4.01B
3.58B
4.02B
Cost of goods sold
2.38B
2.57B
2.42B
2.70B
Cost of revenue
2.38B
2.57B
2.42B
2.70B
Research and development expenses
141.14M
184.42M
139.77M
156.06M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
540.84M
553.55M
520.12M
587.74M
Operating expense
744.80M
809.09M
701.15M
782.02M
Total operating expenses
3.13B
3.38B
3.12B
3.48B
Operating income
519.36M
629.52M
461.69M
538.28M
Other non operating income
-37.81M
36.17M
-48.69M
46.54M
EBT including unusual items
516.18M
583.78M
412.76M
513.42M
EBT excluding unusual items
478.50M
626.67M
396.21M
436.35M
Income tax expense
102.94M
94.46M
102.35M
112.13M
Effective tax rate
19.94%
16.18%
24.80%
21.84%
Other operating expenses
56.34M
34.47M
29.75M
32.75M
Net income
439.52M
522.99M
335.36M
414.83M
Net profit margin
12.06%
13.04%
9.37%
10.33%
Earnings per share
0.27
0.33
-
-
Interest and investment income
12.46M
9.47M
34.76M
16.83M
Interest expense
-47.49M
-51.15M
-51.56M
-48.40M
Net interest expenses
-35.03M
-41.68M
-16.80M
-31.58M
Depreciation and amortization charges
-
-
-
-
EBITDA
735.19M
881.17M
713.34M
834.44M
Gain or loss from assets sale
-3.36M
4.69M
-
-5.29M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps